Gilead Sciences (GILD) Liabilities and Shareholders Equity (2009 - 2026)
Gilead Sciences (GILD) posted Liabilities and Shareholders Equity of $49.36 billion for Q2 2026, down 11.4% from $55.72 billion a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Liabilities and Shareholders Equity came in at $59.02 billion, unchanged from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- In prior years, Gilead Sciences' Liabilities and Shareholders Equity was $59 billion in FY2024 (-5.0%), $62.13 billion in FY2023 (-1.7%), $63.17 billion in FY2022 (-7.0%) and $67.95 billion in FY2021 (-0.7%).
- The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q1 2016.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last eight quarters, with an average decline of 2.2%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 10.2%; the weakest was Q2 2024, with a decline of 14.0%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $56.28 billion (Q1 2026), $59.02 billion (Q4 2025) and $58.53 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 27.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.36 Bn |
| Mar 31, 2026 | 56.28 Bn |
| Dec 31, 2025 | 59.02 Bn |
| Sep 30, 2025 | 58.53 Bn |
| Jun 30, 2025 | 55.72 Bn |
| Mar 31, 2025 | 56.43 Bn |
| Dec 31, 2024 | 59.00 Bn |
| Sep 30, 2024 | 54.53 Bn |
| Jun 30, 2024 | 53.58 Bn |
| Mar 31, 2024 | 56.29 Bn |
| Dec 31, 2023 | 62.13 Bn |
| Sep 30, 2023 | 62.37 Bn |
| Jun 30, 2023 | 62.34 Bn |
| Mar 31, 2023 | 61.88 Bn |
| Dec 31, 2022 | 63.17 Bn |
| Sep 30, 2022 | 62.56 Bn |
| Jun 30, 2022 | 62.87 Bn |
| Mar 31, 2022 | 63.08 Bn |
| Dec 31, 2021 | 67.95 Bn |
| Sep 30, 2021 | 67.10 Bn |
API Access
Gilead Sciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();